🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/05/2011 | 34,78 | 34,96 | 34,51 | 34,59 | -0,85% | 1,29% | 17.279.214 |
| 04/05/2011 | 34,69 | 35,07 | 34,61 | 34,89 | +0,41% | 1,32% | 18.234.257 |
| 03/05/2011 | 34,58 | 34,96 | 34,42 | 34,74 | +0,28% | 1,57% | 18.571.713 |
| 02/05/2011 | 34,77 | 34,90 | 34,52 | 34,65 | +1,00% | 1,10% | 19.269.890 |
| 29/04/2011 | 34,33 | 34,59 | 34,00 | 34,30 | +0,50% | 1,72% | 19.843.880 |
| 28/04/2011 | 34,01 | 34,16 | 33,84 | 34,13 | +0,39% | 0,95% | 14.096.962 |
| 27/04/2011 | 33,59 | 34,10 | 33,44 | 34,00 | +1,63% | 1,96% | 21.360.860 |
| 26/04/2011 | 32,86 | 33,55 | 32,81 | 33,45 | +2,13% | 2,24% | 22.532.000 |
| 25/04/2011 | 32,16 | 32,82 | 32,09 | 32,76 | +0,85% | 2,28% | 10.088.258 |
| 21/04/2011 | 32,70 | 32,72 | 32,40 | 32,48 | +0,00% | 0,96% | 16.567.832 |
| 20/04/2011 | 32,51 | 32,66 | 32,40 | 32,48 | +0,86% | 0,82% | 14.903.294 |
| 19/04/2011 | 32,39 | 32,55 | 31,98 | 32,20 | -0,53% | 1,74% | 15.922.474 |
| 18/04/2011 | 32,63 | 32,72 | 32,30 | 32,38 | -1,68% | 1,29% | 18.642.558 |
| 15/04/2011 | 33,30 | 33,37 | 32,87 | 32,93 | +1,92% | 1,49% | 38.676.230 |
| 14/04/2011 | 31,81 | 32,48 | 31,75 | 32,31 | +1,17% | 2,31% | 15.740.960 |
| 13/04/2011 | 32,08 | 32,11 | 31,84 | 31,94 | -0,27% | 0,83% | 8.199.447 |
| 12/04/2011 | 31,89 | 32,22 | 31,86 | 32,02 | -0,09% | 1,14% | 15.280.050 |
| 11/04/2011 | 32,14 | 32,30 | 31,98 | 32,05 | -0,24% | 1,01% | 11.719.365 |
| 08/04/2011 | 31,97 | 32,16 | 31,87 | 32,13 | +1,02% | 0,90% | 19.267.585 |
| 07/04/2011 | 31,90 | 31,90 | 31,55 | 31,80 | -0,06% | 1,11% | 13.178.705 |
| 06/04/2011 | 31,76 | 31,92 | 31,63 | 31,82 | +0,57% | 0,90% | 13.667.911 |
| 05/04/2011 | 31,62 | 31,71 | 31,50 | 31,64 | -0,33% | 0,66% | 9.685.930 |
| 04/04/2011 | 31,81 | 31,84 | 31,69 | 31,75 | +0,60% | 0,48% | 12.070.864 |
| 01/04/2011 | 31,54 | 31,73 | 31,49 | 31,56 | +0,18% | 0,76% | 11.993.312 |
| 31/03/2011 | 31,56 | 31,85 | 31,49 | 31,50 | -0,87% | 1,15% | 13.218.424 |
| 30/03/2011 | 31,52 | 31,95 | 31,50 | 31,77 | +1,59% | 1,42% | 18.077.057 |
| 29/03/2011 | 31,00 | 31,30 | 30,94 | 31,28 | +1,02% | 1,17% | 10.397.837 |
| 28/03/2011 | 31,05 | 31,15 | 30,91 | 30,96 | -0,37% | 0,80% | 9.491.526 |
| 25/03/2011 | 31,22 | 31,39 | 31,05 | 31,08 | -0,46% | 1,10% | 11.066.042 |
| 24/03/2011 | 31,33 | 31,39 | 31,05 | 31,22 | +0,28% | 1,10% | 12.035.442 |